Case study with vaccination against Streptococcus uberis infections in 3 dutch dairy herds
Publications
Cattle
Appeared in
National Mastitis Council, 2021
The monovalent vaccine against Strep. uberis (UBAC®, HIPRA) administered to dairy cows following the vaccination schedule implemented in this study, is efficacious in reducing the incidence of clinical mastitis, Strep. uberis subclinical mastitis and antibiotic use intramammary on herd level during a whole year period in herds with presence of this agent.
The objective of this study is to compare the serological evolution of serum samples from broilers with maternal immunity from different farms in France that were subsequently vaccinated. To do this, four commercially available kits were used: CIVTEST AVI IBD (HIPRA), ELISA-I, ELISA-S and ELISA-B; all of them are indirect ELISA kits.
Serodiagnosis of Gumboro disease comparing CIVTEST® AVI IBD with 3 other commercial kits. The objective of this study is to compare the serological evolution.
Download this article
Related services
An innovative service based on data analysis that facilitates decision-making in Cattle
HIPRA Stats is a data analysis service for animal production companies.
This online calculator will allow you to know your farm costs, find out the costs associated with clinical and subclinical mastitis and analyse the production losses associated with mastitis
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
HIPRA has specially developed several online tools to support veterinarians and other Animal Health professionals in their daily work.
Access an advanced diagnostic service with maximum comfort and reliability
Related products
Live marker vaccine against BoHV-1 (gE- tk- double-gene deleted) in emulsion for injection
Multivalent viral vaccine against BRSV, BVDV types 1 & 2 and PI3V in emulsion for injection.
Multivalent viral vaccine against BRSV, IBR, BVDV types 1 & 2 and PI3V in emulsion for injection.
Live vaccine against Bovine Respiratory Syncytial Virus (BRSV), in suspension for injection or nasal spray for cattle.
Subunit vaccine against mastitis caused by Streptococcus uberis, in injectable emulsion
Polyvalent inactivated vaccine against bovine mastitis, in injectable emulsion
Inactivated vaccine against pneumonia caused by Histophilus somni and Mannheimia haemolytica leukotoxoid, in injectable emulsion.
Live vaccine (double gene deleted gE-/tk-) against IBR virus, in injectable freeze-dried tablet
Combined vaccine against IBR, PI3, BVD and BRS viruses, in injectable suspension
Inactivated vaccine against infectious bovine keratoconjunctivitis, in injectable suspension
Combined vaccine against PI3, BVD and BRS viruses, in injectable suspension
Inactivated vaccine against enterotoxaemia, tetanus and blackleg, in injectable suspension
